Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or California for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to California only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. California (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Nathan Steinle (NPI 1942455423)

Field	Value
Entity Type	Individual
Organization	Nathan Steinle
Address	525 E Micheltorena St Ste A
City	Santa Barbara
State	CA
ZIP	93103
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	November 25, 2008

Payer Source	Total Paid
Medicare	$9.5M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: Total Medicare revenue: $9.5M while Total Medicaid revenue: none (no Medicaid billing on file), so Medicare accounts for the entirety of recorded public‑payer activity. The NPI was enumerated on 2008-11-25 (~18 years ago), indicating an established practice likely with an enduring referral base and operational history to generate the observed volumes.

Revenue is heavily concentrated in a small set of intravitreal drug codes: the precomputed top‑3 Medicare codes by revenue account for 56.4% of this provider's total Medicare revenue. Specifically, J0178 ($2.8M, 30.3%), Q5128 ($1.3M, 13.9%), and J2777 ($1.1M, 12.2%) together dominate the Medicare revenue mix, signaling dependence on high‑volume injectable therapeutics.

Clinical/service‑line profile is retina‑focused: the top revenue drivers (J0178, Q5128, J2777) are intravitreal injections for agents used to treat retinal disease, and high counts for 92014 and 92134 show heavy use of comprehensive visits and retinal imaging. Combined with frequent injection procedure code 67028 ($509.6K) and other vitreoretinal surgery codes on file, the code mix is consistent with a clinic that delivers recurrent, office‑based anti‑VEGF/faricimab therapy and associated diagnostic imaging.

Competitive standing by code shows national prominence for several items: Q5128 ranks #9 of 373 providers nationally and is labeled an extreme outlier (98th percentile), and J0178 ranks #64 of 3204 (98th percentile; notably above typical national volume for this code). In contrast, J2777 ranks #170 of 2039 (92nd percentile) and is described as typical/unremarkable volume, so the provider is especially dominant for certain biologic agents while more typical for others.

Operational intensity is reflected in extremely high national ranks for routine ophthalmology services and retinal imaging: 92014 (6.4K claims, $649.6K) ranks #1 of 35415 providers nationally (100th percentile; extreme outlier) and 92134 (8.7K claims, $285.9K) also ranks #1 of 26868 providers (100th percentile; extreme outlier). These two items indicate an unusually large established‑patient panel and very high throughput of retinal diagnostic imaging that supports the injectable treatment volumes.

The practice also bills sizable amounts for unclassified/high‑cost drug lines: J3490 (561 claims, $888.1K, 9.5%) carries a high avg paid/claim ($1583) and ranks #89 of 2838 providers (97th percentile; typical, unremarkable volume), while compounded drug billing (J7999) appears at lower revenue. This pattern suggests meaningful use of nonstandard or high‑unit drug administrations in addition to branded/biosimilar injectables.

Surgical retina activity is present but represents a small share of revenue: several vitrectomy and retinal repair codes appear (for example, 67028 with $509.6K and ranks #15 of 4255, 100th percentile; extreme outlier, and 67039 $86.3K, rank #1 of 121, 100th percentile), indicating the provider performs both high‑frequency injections and a smaller volume of operative procedures. The mix implies a clinic that prioritizes office‑based retina therapeutics and imaging while maintaining capacity for surgical interventions.

The narrow payer mix (Medicare only on file) combined with unusually high volumes for a small set of drug and visit codes (several labeled extreme outlier or notably above typical national volume) points to market concentration risk: the provider appears highly reliant on Medicare reimbursement for anti‑VEGF/faricimab administrations and associated visits, which could affect negotiating leverage or risk exposure if payer policies or drug utilization patterns shift.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

39 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	4,130	$690	$2.8M
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	6,020	$220	$1.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	39,420	$30	$1.1M
J3490	Unclassified drugs	560	$1,580	$888.1K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	4,540	$180	$799K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	6,370	$100	$649.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	4,470	$110	$509.6K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	3,390	$120	$406.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	8,660	$30	$285.9K
67039	The provider removes vitreous humor from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. This procedure also includes the…	110	$800	$86.3K

Showing 1–10 of 39

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 39 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. California Distribution

Nathan Steinle — 13 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — California

Full comparison — all codes billed, vs. state median

39 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	310	570	$690	$647.1K
J2777	17	200	10,740	$30	$459.5K
Q5128	3	50	800	$220	$286.7K
Q5124	1	30	810	$170	$217.3K
J2778	92	130	700	$180	$196K
J2781	2	60	480	$120	$95.7K
67028	2	470	420	$100	$71.8K
J3490	28	320	80	$190	$49.2K
J7312	2	40	240	$160	$40.5K
J7999	84	240	130	$140	$34.9K

Showing 1–10 of 39

Related Providers

Other providers that share a Tax Identification Number (TIN) with Nathan Steinle, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Aaron Jeng	CA	Internal Medicine Physician	$43.2M	$0
Richard Park	CA	Internal Medicine Physician	$31.7M	$0
Harbinder Brar	CA	Maternal & Fetal Medicine Physician	$0	$31.3M
Riverside Radiology And Interventional Associates Inc	OH	Diagnostic Radiology Physician	$0	$30.3M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Sansum Clinic	CA	Multi-Specialty Clinic/Center	$0	$24.4M
Jack Azad	CA	General Practice Physician	$17.2M	$0
Retina And Vitreous Associates Of Kentucky PLLC	KY	Retina Specialist (Ophthalmology) Physician	$0	$13.3M
Ravindra Gautam	CA	Internal Medicine Physician	$13M	$0

Nearby Providers

Other providers in the same ZIP code as Nathan Steinle, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephen Couvillion	CA	Retina Specialist (Ophthalmology) Physician	$6.4M	$0
Alessandro Castellarin	CA	Retina Specialist (Ophthalmology) Physician	$5.4M	$0
Dilsher Dhoot	CA	Retina Specialist (Ophthalmology) Physician	$5.4M	$0
Daniel Learned	CA	Retina Specialist (Ophthalmology) Physician	$5.1M	$0
Dante Pieramici	CA	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Ma'an Nasir	CA	Retina Specialist (Ophthalmology) Physician	$3M	$0
Bedro Jin	CA	Diagnostic Radiology Physician	$630.8K	$0
Steven Busselen	CA	Family Medicine Physician	$28.5K	$0

Nathan Steinle — Billing Profile & Reimbursement Data

Sign up for Nathan Steinle — Billing Profile & Reimbursement Data policy alerts

Nathan Steinle — Billing Profile & Reimbursement Data

Sign up for Nathan Steinle — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References